Real-time enrollment status for this severe hypertriglyceridemia clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT05681351 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Severe Hypertriglyceridemia |
| Phase | Clinical Trial |
| Target Enrollment | 800 participants |
| Active Locations | 65 sites in the US |
| Sponsor | Ionis Pharmaceuticals, Inc. |
| Last Updated on CT.gov | December 1, 2025 (Dec 1, 2025) |
As of March 2, 2026: Clinical trial NCT05681351 is currently active_not_recruiting participants. This clinical trial study for severe hypertriglyceridemia is not currently accepting new participants at 65 locations across the United States. The study is sponsored by Ionis Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05681351 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 65 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05681351 was last updated Dec 1, 2025 (December 1, 2025). HelloStudys verifies this status automatically.